The cancer that hides its own self-destruct button — and the drug pair that found it

Most cells carry a self-destruct switch: receptors on their surface that tell a damaged cell to die quietly instead of becoming a tumor. In the most aggressive form of kidney cancer, researchers at the University of Notre Dame found that a protein called TRAIL does something cruel — it floods the cell with so much of itself that the self-destruct switches get pulled back inside, where no medicine can reach them, while the cells divide faster. An already-approved kidney cancer drug, belzutifan, turns TRAIL production back down, and the switches drift to the surface again. Pair belzutifan with a laboratory-made version of TRAIL, and far more cancer cells die — in lab dishes and in mouse models alike. Published in the Proceedings of the National Academy of Sciences, the work cures no one yet, but it exposes a hidden weakness in a cancer that too often outruns its treatment.